Company intelligence / Profile preview

Shanghai YuTian Medical Investment Management

Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai YuTian has commercialized cardiac imaging and analysis products based on Ventripoint's knowledge-based reconstruction technology, with VMS (Ventripoint Measurement System) approved for sale and clinical use in China[5].

Therapeutic areas: Cardiovascular
Modalities: Device (knowledge-based reconstruction technology platforms)
Industry: Medical Imaging

Partnerships

Ventripoint Diagnostics (joint venture partner for QAS™ technology and VMS system development and commercialization)[3][5][7][9]

Beyond the preview

Go deeper on Shanghai YuTian Medical Investment Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai YuTian Medical Investment Management.

Explore the full profile